The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

6 Apr 2017 07:00

RNS Number : 7301B
Electrocomponents PLC
06 April 2017
 

Electrocomponents plc today issues a trading update for the year ended 31 March 2017, ahead of publishing full-year results on 23 May 2017.

 

 

Revenue growth(1)

Region

Quarter to Mar 2017

Year to Mar 2017

Northern Europe

5%

5%

Southern Europe

5%

4%

Central Europe

6%

2%

Total Europe

5%

4%

Asia and Emerging Markets

9%

4%

North America

16%

7%

Group

8%

5%

 

We have continued to make strong progress in the final quarter of the year. As a consequence we expect our results for the full year ended 31 March 2017 to be ahead of our previous expectations, with headline profit before tax ahead of the current market consensus range(2).

 

· Q4 revenue growth accelerated to 8% leading to revenue growth of 5% for the full year.

o Our end markets remain strong and the business is executing well, as we continue to improve our go-to-market approach and sales effectiveness. Revenues in the quarter have also benefitted from a more favourable competitive environment in the quarter.

o The acceleration in Q4 revenue growth has been driven by a strong recovery in growth in North America and Asia Pacific, and continued robust growth in Europe.

o RS Pro, our own-brand business, which accounts for around 12% of revenues saw revenue growth of around 5% in Q4.

o eCommerce, which represents around 60% of revenues saw revenue growth of around 8% in Q4, broadly in line with the Group growth rate.

· We expect a similar year-on-year percentage point improvement in the full-year gross margin to that seen in the first-half gross margin. During the final quarter our own actions on price and discount discipline and foreign exchange benefits have offset an unfavourable geographic mix, which relates to faster growth in our lower gross margin North American hub.

· We continue to make good progress on our cost initiatives and are on track to deliver £18 million of net savings in the year to March 2017. However, strong revenue momentum and share price appreciation will lead to higher employee-related incentive costs in the year.

· As we look into 2018, we are also using the strong growth momentum as an opportunity to invest in talent and innovation to drive faster growth in the business in the medium term.

· FY 2017 revenue and profits have seen a significant benefit from foreign exchange(3) and additional trading days(4). As previously guided, in FY 2018 we expect to see an adverse impact on revenues and profits from fewer trading days compared with FY 2017(4).

 

Enquiries:

David Egan

Group Finance Director

01865 204000

Polly Elvin

Investor Relations and Corporate PR

01865 207427

David Allchurch / Martin Robinson

Tulchan Communications

020 7353 4200

Notes:

 

(1) Revenue growth rates, unless otherwise stated, are adjusted for trading days and currency movements ("underlying sales growth").

(2) The market consensus range for headline PBT for the year to March 2017 is £122.3 million to £124.2 million. This range only includes estimates from analysts that have updated forecasts since our latest trading update on 10 February 2017.

(3) Our profits remain sensitive to movements in exchange rates on translation of overseas profits. Positive currency movements increased H1 profit before tax by around £7 million and we expect them to increase full-year profit before tax by around £18 million. Every 1 cent movement in the Euro will have a £1.0 million impact on profits. Every 1 cent movement in US $ will have a £0.3 million impact on profits.

(4) During the year to March 2017 we expect to see around £10 million benefit to revenues from additional trading days compared with FY 2016. In the year to March 2018 we expect to see an adverse impact of around £20 million on revenues from fewer trading days compared with the year to March 2017.

 

Electrocomponents plc - Conference Call Dial in Instructions

 

Date:

Thursday 6 April

UK Time:

08.00h call

 

 

Telephone number:

+44 (0) 1452 55 55 66

PIN:

97347958

 

 

Chairman:

Lindsley Ruth

 

 

Electrocomponents plc - Replay Dial in Instructions (available until 13 April 2017 at 10.30h)

 

Telephone number:

+44 (0) 1452 55 00 00

PIN:

97347958

 

LEI: 549300KVXDURRKVW7R37

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVRBRBSASRAR
Date   Source Headline
5th Apr 20187:00 amRNSTrading Statement
29th Mar 201811:04 amRNSTotal Voting Rights
23rd Mar 20189:45 amRNSDirectorate Change
22nd Mar 20182:12 pmRNSDirector Declaration
20th Mar 201810:51 amRNSNotice of Trading Update
1st Mar 20188:51 amRNSTotal Voting Rights
28th Feb 20184:28 pmRNSBlock listing Interim Review
5th Feb 20187:14 amRNSTrading Update
31st Jan 20184:32 pmRNSTotal Voting Rights
23rd Jan 20181:05 pmRNSNotice of Trading Update
10th Jan 20184:55 pmRNSDirector/PDMR Shareholding
10th Jan 201810:05 amRNSHolding(s) in Company
3rd Jan 20187:00 amRNSUS Tax Legislation
2nd Jan 20189:48 amRNSTotal Voting Rights
19th Dec 201711:58 amRNSDirector/PDMR Shareholding
18th Dec 201710:24 amRNSHolding(s) in Company
18th Dec 20179:51 amRNSDirector/PDMR Shareholding
11th Dec 201711:29 amRNSDirector/PDMR Shareholding
1st Dec 201712:00 pmRNSUS Site visit
30th Nov 20173:07 pmRNSTotal Voting Rights
14th Nov 20177:00 amRNSHalf-year Report
31st Oct 20171:34 pmRNSTotal Voting Rights
18th Oct 201711:16 amRNSHolding(s) in Company
3rd Oct 20177:00 amRNSTrading Update
21st Sep 20179:49 amRNSNotice of trading update
31st Aug 201710:20 amRNSTotal Voting Rights
16th Aug 201711:16 amRNSHolding(s) in Company
14th Aug 201711:35 amRNSHolding(s) in Company
9th Aug 20178:16 amRNSAdditional Listing
1st Aug 201711:44 amRNSBlock listing Interim Review
31st Jul 201710:57 amRNSTotal Voting Rights
20th Jul 201711:49 amRNSResult of AGM
19th Jul 201712:42 pmRNSHolding(s) in Company
3rd Jul 20177:00 amRNSElectrocomponents Plc Trading Statement
30th Jun 20179:43 amRNSTotal Voting Rights
14th Jun 201712:11 pmRNSHolding(s) in Company
2nd Jun 20173:04 pmRNSAnnual Financial Report
31st May 201711:55 amRNSTotal Voting Rights
26th May 20174:31 pmRNSDirector/PDMR Shareholding
26th May 20174:29 pmRNSDirector/PDMR Shareholding
23rd May 20177:00 amRNSFull-year results for the year ended 31 March 2017
22nd May 201711:15 amRNSHolding(s) in Company
3rd May 20178:53 amRNSTotal Voting Rights
20th Apr 201712:55 pmRNSHolding(s) in Company
6th Apr 20177:00 amRNSTrading update
5th Apr 20174:31 pmRNSDirectorate Change
31st Mar 201710:46 amRNSTotal Voting Rights
23rd Mar 20172:26 pmRNSNotice of trading update
20th Mar 20179:28 amRNSDirector/PDMR Shareholding
15th Mar 20179:55 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.